Simplex Trading
TAK icon

Simplex Trading’s Takeda Pharmaceutical TAK Stock Holding History

Simplex Trading’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.02K Sell
500
-2,100
-81% -$34.7K ﹤0.01% 7858
2026
Q1 		$48.2K Buy
+2,600
New +$45.6K ﹤0.01% 5923
2025
Q3 		– Sell
-100
Closed -$1K – 10051
2025
Q2 		$1K Sell
100
-800
-89% -$11.8K ﹤0.01% 8437
2025
Q1 		$13K Buy
900
+600
+200% +$8.41K ﹤0.01% 6937
2024
Q4 		$3K Hold
300
– – ﹤0.01% 7931
2024
Q3 		$4K Buy
300
+100
+50% +$1.42K ﹤0.01% 7775
2024
Q2 		$2K Sell
200
-800
-80% -$10.6K ﹤0.01% 8355
2024
Q1 		$13K Hold
1,000
– – ﹤0.01% 7438
2023
Q4 		$14K Buy
+1,000
New +$14.2K ﹤0.01% 7207
2023
Q3 		– Sell
-3,700
Closed -$58K – 9792
2023
Q2 		$58K Sell
3,700
-5,200
-58% -$85.2K ﹤0.01% 5701
2023
Q1 		$146K Buy
8,900
+6,800
+324% +$108K ﹤0.01% 4705
2022
Q4 		$32K Sell
2,100
-3,300
-61% -$46.1K ﹤0.01% 6395
2022
Q3 		$70K Buy
5,400
+4,700
+671% +$65.4K ﹤0.01% 5996
2022
Q2 		$9K Sell
700
-6,700
-91% -$95.6K ﹤0.01% 8395
2022
Q1 		$105K Sell
7,400
-5,000
-40% -$73.4K ﹤0.01% 6067
2021
Q4 		$169K Sell
12,400
-26,000
-68% -$365K ﹤0.01% 5429
2021
Q3 		$648K Hold
38,400
– – ﹤0.01% 3711
2021
Q2 		$646K Buy
38,400
+37,380
+3,665% +$636K ﹤0.01% 3763
2021
Q1 		$1.86M Buy
1,020
+745
+271% +$13.4K ﹤0.01% 1684
2020
Q4 		$500K Sell
275
-38
-12% -$667 ﹤0.01% 3428
2020
Q3 		$558K Sell
313
-6
-2% -$109 ﹤0.01% 2854
2020
Q2 		$571K Buy
319
+10
+3% +$180 ﹤0.01% 2749
2020
Q1 		$468K Buy
+309
New +$5.6K ﹤0.01% 2665

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Simplex Trading's TAK Position: Q2 2026 in Review

Simplex Trading sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 5,146 shares — an estimated $85.2K sold.

Simplex Trading first reported a position in TAK in Q3 2019 and held it in 9 quarters. The position peaked at $535K in Q2 2021. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Simplex Trading reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 5,146 Takeda Pharmaceutical shares in Q2 2026, an estimated $85.2K.
  • Simplex Trading first reported a position in Takeda Pharmaceutical in Q3 2019 and held it in 9 quarters.
  • Simplex Trading's Takeda Pharmaceutical position peaked at $535K in Q2 2021.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.